跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lotencin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lotencin
Approved
STANDARD
Lotencin
Daewon Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
93bb88e6edb4285d
Company
Daewon Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
93bb88e6edb4285d
Drug Approval Philippines Name
Lotencin
Product Name
Lotencin
Registration Number
DR-XY29935
Brand Name
Lotencin
Generic Name
Terazosin (as Hydrochloride Dihydrate)
Dosage Form
Tablet
Dosage Strength
2 mg
Manufacturer
Daewon Pharm. Co., Ltd.
Importer
Hexagon Pharmaceuticals
Distributor
Genace Pharma Distributor
Issuance Date
27 April 2024
Expiry Date
01 September 2029
Pharmacologic Category
Alpha-adrenoreceptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
93bb88e6edb4285d
Type
Standard
Back to Philippines FDA Approvals